Child GO terms
- Original GO term
- GO:0009611
- Description
- response to wounding
- Type
- BP
GO | description | genes | species | aly | ath | atr | bra | bvu | cla | cme | cpa | cre | cru | csi | egr | fve | gma | gra | lja | mdo | mes | mtr | olu | osa | ppa | ppe | ptr | rco | sly | stu | tca | tpa | vvi | zma |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GO:0009861 | jasmonic acid and ethylene-dependent systemic resistance | 565 | 31 | 23 | 23 | 12 | 35 | 9 | 17 | 17 | 12 | 2 | 30 | 13 | 19 | 15 | 27 | 23 | 12 | 29 | 16 | 39 | 3 | 19 | 12 | 15 | 21 | 12 | 28 | 20 | 17 | 18 | 11 | 16 |
GO:0009871 | jasmonic acid and ethylene-dependent systemic resistance, ethylene mediated signaling pathway | 238 | 29 | 7 | 7 | 5 | 8 | 4 | 9 | 9 | 6 | 0 | 9 | 5 | 13 | 8 | 13 | 12 | 6 | 17 | 8 | 8 | 0 | 8 | 6 | 8 | 11 | 6 | 13 | 8 | 10 | 6 | 5 | 3 |
GO:0032260 | response to jasmonic acid stimulus involved in jasmonic acid and ethylene-dependent systemic resistance | 90 | 31 | 4 | 4 | 3 | 10 | 2 | 2 | 3 | 3 | 1 | 4 | 2 | 2 | 4 | 3 | 2 | 1 | 2 | 3 | 2 | 2 | 4 | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 5 | 2 | 4 |
GO:0009868 | jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway | 67 | 31 | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 1 | 2 | 2 | 2 | 3 | 2 | 2 | 1 | 2 | 3 | 2 | 1 | 3 | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
GO:0042060 | wound healing | 52 | 31 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 4 | 1 | 2 | 1 | 1 | 3 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 1 | 2 | 3 | 1 | 2 | 2 | 1 | 1 | 1 | 3 |
GO:0006954 | inflammatory response | 51 | 28 | 1 | 6 | 1 | 1 | 1 | 1 | 2 | 4 | 6 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 0 | 9 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
GO:0002526 | acute inflammatory response | 46 | 28 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 6 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 0 | 9 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
GO:0001778 | plasma membrane repair | 45 | 31 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 1 | 2 | 3 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
GO:0006953 | acute-phase response | 29 | 27 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
GO:0002437 | inflammatory response to antigenic stimulus | 17 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016068 | type I hypersensitivity | 17 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0002524 | hypersensitivity | 17 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 17 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0007596 | blood coagulation | 6 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
GO:0002540 | leukotriene production involved in inflammatory response | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0002538 | arachidonic acid metabolite production involved in inflammatory response | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0002532 | production of molecular mediator involved in inflammatory response | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0042381 | hemolymph coagulation | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |